|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_MaterialEventDisclosureGeneralAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
It has previously been disclosed to the public that our Company, with its IVEIN branded product group manufactured with a 95% domestic production rate , has been selected as a successful supplier in the tender conducted by the NHS – National Health Service , affiliated with the UK Department of Health, to meet the needs of approximately 700 hospitals , and that the relevant contract has been duly executed.
Within the scope of the said tender, which has a total budget of GBP 115 million (approximately TRY 6.4 billion ) and will continue for a 2+2 year period:
· The third shipment was successfully carried out as 1 truckload as of Wednesday, 31 December 2025 .
It is anticipated that the shipments will continue as planned in the coming months .
The ongoing supply activities are expected to have a positive and strong impact on the Company's financial results for the year 2025 .
This announcement is respectfully submitted to the public.
|
||||||||